IntrinsicIntrinsic
← Scroll for more →

Financial Statements — CGCTW

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q1 2025
Cash & Equivalents112.830.000.000.0041.72
Total Current Assets115.600.510.830.96--
Property, Plant & Equipment19.2220.21------
Total Non-current Assets*27.0561.88280.74277.86--
Total Assets142.6562.39281.56278.820.71
Accounts Payable0.720.66------
Total Current Liabilities6.601.390.400.420.74
Total Non-current Liabilities*51.0613.1413.1413.140.00
Total Liabilities*57.6614.5313.5413.560.74
Retained Earnings(275.49)(14.01)(12.65)(12.51)(0.06)
Total Stockholder Equity85.00(14.01)(12.65)(12.51)(0.04)
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Research & Development6.581.94------6.75
Selling, General & Admin6.380.810.550.140.450.02
Total Operating Expenses12.96----------
Operating Income(12.96)(0.81)(0.55)(0.14)(0.45)(0.02)
Pretax Income(11.34)(8.57)------(12.87)
Tax Provision0.000.000.000.000.000.00
Net Income(11.34)1.682.162.761.32(0.02)
Basic EPS(0.61)(1.70)------(2.57)
Diluted EPS(0.85)(1.70)------(2.57)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Operating Cash Flow(11.16)(0.23)(0.04)(0.17)(0.30)(6.10)
Capital Expenditures0.560.48------0.17
Free Cash Flow*(11.72)(0.71)------(6.27)
Investing Cash Flow(0.58)(0.49)0.000.00(276.00)(0.17)
Financing Cash Flow96.093.300.000.00277.13(0.20)
← Scroll for more columns →

* Derived from reported values